Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a

被引：0
|
作者：
Alteri, E. [1 ]
Kornmann, G. [1 ]
Moraga, M. Stam [1 ]
Casset-Semanaz, F. [1 ]
Miret, M. [1 ]
机构：
[1] Merck Serono SA, Geneva, Switzerland
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2009年 / 285卷
关键词：
D O I：
10.1016/S0022-510X(09)70783-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S204 / S205
页数：2
相关论文
共 50 条
  • [1] Risk of stroke in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Sabido-Espin, M.
    Venkatesh, S.
    Aldridge, J.
    Gillett, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1022 - 1022
  • [2] Risk of Stroke in Patients with Multiple Sclerosis Treated with Subcutaneous Interferon beta-1a (scIFNβ-1a)
    Sabido, Meritxell
    Venkatesh, Saritha
    Aldridge, Julie
    Gillett, Alan
    [J]. NEUROLOGY, 2018, 90
  • [3] Assessing the Risk of Malignancy in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon beta-1a
    Sandberg-Wollheim, Magnhild
    Kornmann, Gabrielle
    Moraga, Margaretha Stam
    Miret, Montserrat
    Alteri, Enrica
    [J]. NEUROLOGY, 2010, 74 (09) : A61 - A62
  • [4] Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis
    Freedman, Mark S.
    Jack, Dominic
    Murgasova, Zuzana
    Todorovic, Milorad
    Seitzinger, Andrea
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [5] Subcutaneous Interferon beta-1a Treatment and Pregnancy Outcomes in Patients with Multiple Sclerosis
    Sandberg-Wollheim, Magnhild
    Alteri, Enrica
    Moraga, Margaretha Stam
    Kornmann, Gabrielle
    [J]. NEUROLOGY, 2010, 74 (09) : A404 - A404
  • [6] AUtoimmunity PRofile in INterferon beta-1a treated multiple sclerosis patients. The AUPRIN Study: Comparison of 2 different dosages of subcutaneous interferon beta-1a
    Verdun, E
    Giordano, L
    Cucci, MA
    Ricci, A
    Barbero, P
    Pipieri, A
    Clerico, M
    Aimo, G
    Durelli, L
    [J]. NEUROLOGY, 2005, 64 (06) : A384 - A385
  • [7] Cholecalciferol supplementation in relapsing multiple sclerosis patients treated with subcutaneous interferon beta-1a: a randomized controlled trial
    Camu, W.
    Pierrot-Deseilligny, C.
    Hautecoeur, P.
    Besserve, A.
    Deleglise, A. -S. Jean
    Lehert, P.
    Souberbielle, J. -C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 373 - 374
  • [8] Cognition and fatigue in patients with relapsing multiple sclerosis treated by subcutaneous interferon beta-1a: an observational study SKORE
    Benesova, Y.
    Tvaroh, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 409 - 409
  • [9] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    [J]. JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [10] Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
    Pohl, D
    Rostasy, K
    Gärtner, J
    Hanefeld, F
    [J]. NEUROLOGY, 2005, 64 (05) : 888 - 890
12345